Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions like schizophrenia or depression.

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the microenvironment is too tumor-friendly. Researchers at the University of Basel and University Hospital Basel have now developed an immunotherapy that not only attacks the tumor-it also turns its microenvironment against it.

Women earn more if they mostly went to school with other girls as children, report researchers at the University of Basel and Durham University. Their findings are based on data from 750,000 schoolchildren.

Researchers from Switzerland and Kenya have investigated how climate change, urbanization and malaria control measures affect the risk of malaria in Kenya. The results show that despite a general decline, the risk of malaria has increased significantly in some regions.

Opinions differ on the issue of the coin: some find small change annoying, others collect coins. Rahel C. Ackermann deals with coins in her research. In this interview, the archaeologist and numismatist explains why they are worth a closer look, and how closely coins and customs are intertwined.

The right to vote is an important part of a democracy. But not everyone makes use of it. A researcher at the University of Basel has investigated the possible causes of this.

Over time, the English language has acquired quite a few Yiddish words, such as bagel. Some are now no longer even recognizable as such. Linguist Julia Landmann from the University of Basel has collected these terms and classified them according to their social history.

Drug tolerant bacteria pose a major challenge, because they can survive antibiotic therapies and cause recurrent infections. Researchers at the University of Basel have discovered how a dangerous human pathogen causing pneumonia uses a kind of molecular "sleeping pill" to enter a dormant state and by that persist antibiotic treatment. The findings suggest that this survival strategy may play an important role during chronic infections.